Welcome to LookChem.com Sign In|Join Free

CAS

  • or

263410-16-8

Post Buying Request

263410-16-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

263410-16-8 Usage

General Description

Tert-butyl (2-(2-aminophenoxy)ethyl)carbamate is a chemical compound that belongs to the carbamate group. It is derived from tert-butyl isocyanate and 2-(2-aminophenoxy) ethanol. tert-butyl (2-(2-aminophenoxy)ethyl)carbamate is used in the production of pesticides and insecticides due to its ability to act as a carbamate pesticide that inhibits the activity of acetylcholinesterase enzymes in target organisms. It is also used as a stabilizer in polymers and plastics to improve their thermal and UV resistance. However, it is important to note that this chemical compound can be harmful to human health and the environment if not handled properly, and caution should be exercised when using products containing tert-butyl (2-(2-aminophenoxy)ethyl)carbamate.

Check Digit Verification of cas no

The CAS Registry Mumber 263410-16-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,4,1 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 263410-16:
(8*2)+(7*6)+(6*3)+(5*4)+(4*1)+(3*0)+(2*1)+(1*6)=108
108 % 10 = 8
So 263410-16-8 is a valid CAS Registry Number.

263410-16-8Relevant articles and documents

Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery

Tykvart, Jan,Schimer, Jiri,Barinkova, Jitka,Pachl, Petr,Postova-Slavetinska, Lenka,Majer, Pavel,Konvalinka, Jan,Sacha, Pavel

supporting information, p. 4099 - 4108 (2014/08/18)

Glutamate carboxypeptidase II (GCPII), also known as prostate specific membrane antigen (PSMA), is an established prostate cancer marker and is considered a promising target for specific anticancer drug delivery. Low-molecular-weight inhibitors of GCPII are advantageous specific ligands for this purpose. However, they must be modified with a linker to enable connection of the ligand with an imaging molecule, anticancer drug, and/or nanocarrier. Here, we describe a structure-activity relationship (SAR) study of GCPII inhibitors with linkers suitable for imaging and drug delivery. Structure-assisted inhibitor design and targeting of a specific GCPII exosite resulted in a 7-fold improvement in Ki value compared to the parent structure. X-ray structural analysis of the inhibitor series led to the identification of several inhibitor binding modes. We also optimized the length of the inhibitor linker for effective attachment to a biotin-binding molecule and showed that the optimized inhibitor could be used to target nanoparticles to cells expressing GCPII.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 263410-16-8